Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 70,400 | 108,389 | 138,394 | 185,729 | 112,902 |
| Operating Income | -70,400 | -108,389 | -138,394 | -185,729 | -112,902 |
| Other Income | 5,633 | 6,327 | 2,269 | 343 | 670 |
| Pre-tax Income | -64,767 | -102,062 | -136,125 | -185,386 | -112,232 |
| Net Income Continuous | -64,767 | -102,062 | -136,125 | -185,386 | -112,232 |
| Net Income | $-64,767 | $-102,062 | $-136,125 | $-185,386 | $-112,232 |
| EPS Basic Total Ops | -21.40 | -37.20 | -50.00 | -69.60 | -58.20 |
| EPS Basic Continuous Ops | -21.44 | -37.29 | -50.02 | -69.51 | -58.13 |
| EPS Diluted Total Ops | -21.40 | -37.20 | -50.00 | -69.60 | -58.20 |
| EPS Diluted Continuous Ops | -21.44 | -37.29 | -50.02 | -69.51 | -58.13 |
| EPS Diluted Before Non-Recurring Items | -21.40 | -37.20 | -50.00 | -66.60 | -58.20 |
| EBITDA(a) | $-68,846 | $-106,704 | $-133,942 | $-181,408 | $-111,469 |